Utilization and Outcomes Associated With Intravascular Ultrasound during Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016–2023)

医学 血管内超声 危险系数 放射科 腔内修复术 腹主动脉瘤 主动脉瘤 动脉瘤 内科学 外科 心脏病学 置信区间
作者
Ramya Mosarla,Patrick Heindel,Mohamad A. Hussain,Marc L. Schermerhorn,Toshiki Kuno,Mario D’Oria,Siling Li,Eric A. Secemsky
出处
期刊:Circulation-cardiovascular Interventions [Lippincott Williams & Wilkins]
标识
DOI:10.1161/circinterventions.124.014332
摘要

BACKGROUND: Intravascular ultrasound (IVUS) use in aortic endovascular interventions, including thoracic endovascular aneurysm repair (TEVAR) and endovascular aneurysm repair (EVAR), may have similar benefits to those seen in coronary and peripheral interventions, but limited utilization and outcome data exist. METHODS: Centers for Medicare and Medicaid Services claims data were used to identify patients undergoing TEVAR and EVAR from 2016 to 2023. Utilization trends were stratified by region, urbanicity, distressed communities index, community versus academic center, Medicare versus dual enrollment status, indication, urgency, and presence of dissection with malperfusion. Inverse probability weighting was used to assess the impact of IVUS on a composite outcome of repeat aortic intervention or death. Cox regression was used to estimate weighted hazard ratios. RESULTS: A total of 136 540 patients underwent TEVAR and EVAR, of which 9.8% (13 364) used IVUS. IVUS use increased slightly from 2016 to 2023, driven more by use in TEVAR compared with EVAR, and was higher in academic settings, with Medicare and Medicaid dual enrollment, in the West, with dissections, with malperfusion and for elective procedures. IVUS was associated with a lower risk of the primary outcome at 30-days (hazard ratio, 0.80 [95% CI, 0.73–0.89]; P <0.001) and 6-months (hazard ratio, 0.93 [95% CI, 0.87–0.99]; P =0.022) for all-comers. Subgroup analysis suggested lower risks of the primary outcome with IVUS use for aneurysm driven by the abdominal segment, malperfusion, thoracoabdominal dissection with malperfusion, thoracoabdominal repair, and chronic kidney disease. CONCLUSIONS: IVUS use has increased slightly in TEVAR and EVAR with heterogeneity in use. IVUS implementation during TEVAR and EVAR was associated with improved early and mid-term outcomes, particularly in certain subsets.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Rain完成签到,获得积分10
刚刚
打打应助whh采纳,获得10
1秒前
1秒前
momo完成签到,获得积分10
2秒前
兴奋书雪完成签到,获得积分10
3秒前
星辰大海应助SRsora采纳,获得10
3秒前
金虎完成签到,获得积分10
3秒前
京兆尹完成签到,获得积分10
4秒前
lulu发布了新的文献求助10
5秒前
思源应助毛毛采纳,获得10
6秒前
treasure完成签到,获得积分10
7秒前
momo发布了新的文献求助10
7秒前
8秒前
傲娇诗完成签到,获得积分10
11秒前
tjbdlyh完成签到 ,获得积分10
12秒前
奎奎发布了新的文献求助10
14秒前
14秒前
柚子完成签到 ,获得积分10
16秒前
李昆朋完成签到,获得积分10
18秒前
18秒前
火星上的沛春完成签到,获得积分10
19秒前
19秒前
深情安青应助话哈哈采纳,获得10
19秒前
22秒前
SRsora发布了新的文献求助10
24秒前
CipherSage应助摩登灰太狼采纳,获得10
24秒前
24秒前
柔之完成签到,获得积分10
26秒前
UYang发布了新的文献求助10
26秒前
26秒前
leid完成签到 ,获得积分10
28秒前
七羽完成签到 ,获得积分10
28秒前
乐乐应助Richard采纳,获得10
28秒前
稳重乌冬面完成签到 ,获得积分10
28秒前
31秒前
Leee发布了新的文献求助10
31秒前
32秒前
SRsora发布了新的文献求助10
32秒前
34秒前
明理的小蘑菇关注了科研通微信公众号
34秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Encyclopedia of Geology (2nd Edition) 2000
Maneuvering of a Damaged Navy Combatant 650
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
Mixing the elements of mass customisation 300
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3780178
求助须知:如何正确求助?哪些是违规求助? 3325465
关于积分的说明 10223213
捐赠科研通 3040677
什么是DOI,文献DOI怎么找? 1668962
邀请新用户注册赠送积分活动 798878
科研通“疑难数据库(出版商)”最低求助积分说明 758634